breast cancer therapy - Robuta Search

https://tedrogersresearch.ca/2016/04/breast-cancer-therapy-related-cardiac-dysfunction/ Breast cancer therapy-related cardiac dysfunction | Ted Rogers Centre for Heart Research Sep 29, 2022 - Protecting patient hearts from Herceptin breast cancer therapy cardiac dysfunction rogers centre heart research related https://www.clinicaltrialsarena.com/news/shanghai-henlius-breast-cancer/ Shanghai Henlius secures AEMPS approval for breast cancer therapy trial Oct 31, 2022 - Shanghai Henlius Biotech has received approval from the AEMPS for a Phase III clinical trial of its pertuzumab biosimilar HLX11. breast cancer therapy shanghai approval trial https://rjppd.org/AbstractView.aspx?PID=2013-5-6-18 RJPPD - An overview on current Strategies in Breast Cancer Therapy Breast cancer is the most common forms of female cancers. External factors like obesity, late pregnancies or no pregnancies, use of tobacco and alcohol have... breast cancer therapy overview current strategies https://bioengineer.org/arx788-combo-outperforms-standard-her2-breast-cancer-therapy/ ARX788 Combo Outperforms Standard HER2+ Breast Cancer Therapy Sep 6, 2025 - In a groundbreaking phase 2b clinical trial published in Nature Communications, researchers have explored an innovative therapeutic approach for HER2-positive... breast cancer therapy combo standard https://www.techscience.com/or/v33n4/60042 OR | Targeting MDM2-p53 interaction for breast cancer therapy Breast cancer is a significant global concern, with limited effective treatment options. Therefore, therapies with high efficacy and low complications, unlike... breast cancer therapy targeting interaction https://www.guthrie.org/BreastCancerTherapyGroup Breast Cancer Therapy Group | Guthrie The Breast Cancer Therapy Group, led by Clinical Health Psychologist Danielle Terry, PhD, ABPP, is geared towards helping individuals in the beginning, middle... breast cancer therapy group guthrie https://pmc.ncbi.nlm.nih.gov/articles/PMC10926878/ Glutathione Depletion-Induced ROS/NO Generation for Cascade Breast Cancer Therapy and Enhanced... As an effective alternative choice to traditional mono-therapy, multifunctional nanoplatforms hold great promise for cancer therapy. Based on the strategies of... breast cancer therapy glutathione depletion ros generation cascade https://www.mdpi.com/2218-273X/14/10/1219 Molecular Targets for Breast Cancer Therapy Breast cancer is by far the most common cancer in women, and for a while, it surpassed lung cancer as the most diagnosed cancer, regardless of gender, in 2020... breast cancer therapy molecular targets https://www.acc.org/latest-in-cardiology/clinical-trials/2015/11/11/12/14/prada Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy - American College of... Anthony A. Bavry, M.D., M.P.H., FACC breast cancer therapy cardiac dysfunction american college prevention adjuvant https://www.ijpsjournal.com/article/Redefining+Breast+Cancer+Therapy+An+Integrated+Review+of+PrecisionGuided+Multimodal+Treatment+and+Emerging+Therapeutic+Frontiers Redefining Breast Cancer Therapy: An Integrated Review of Precision-Guided Multimodal Treatment and... breast cancer therapy review of multimodal treatment redefining integrated https://www.massgeneralbrigham.org/en/about/newsroom/press-releases/breast-cancer-therapy-tamoxifen Why Breast Cancer Therapy Tamoxifen May Lead to Higher Risk of Uterine Cancer | Mass General Brigham In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast cancers are treated in the future. breast cancer therapy mass general brigham lead to tamoxifen may https://www.egyptindependent.com/tag/breast_cancer_therapy/ breast cancer therapy Archives - Egypt Independent breast cancer therapy egypt independent archives https://gmu.ac.ae/cop_news/prof-ashraf-khalils-research-seminar-on-novel-triple-negative-breast-cancer-therapy-at-the-college-of-pharmacy/ Seminar on Novel Triple-Negative Breast Cancer Therapy - GMU Apr 21, 2026 - Prof. Ashraf Khalil, Professor of Medicinal Chemistry in the Department of Pharmaceutical Sciences at Dubai Pharmacy College for Girls, Dubai Medical... triple negative breast cancer therapy seminar novel gmu https://brettmaas.com/shares-of-breast-cancer-therapy-developer-olema-pharmaceutical-could-more-than-double-from-here/ Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here |... Oct 30, 2025 - The clinical-stage biopharma stock has rallied more than 70% over the past three months on the back of promising clinical data for its lead drug, Palazestrant. breast cancer therapy more than from here shares developer https://www.cordis.europa.eu/project/id/841313/results/de Machine learning prediction for breast cancer therapy | PredAlgoBC | Projekt | Ergebnisse | H2020 |... Deliverables, publications, datasets, software, exploitable results breast cancer therapy machine learning prediction projekt ergebnisse https://www.counselheal.com/articles/10615/20140725/total-nighttime-darkness-gives-breast-cancer-therapy-boost.htm Total Nighttime Darkness May Enhance Breast Cancer Therapy Jul 25, 2014 - Night lights could cut the success rate of breast cancer therapy, according to a new study. Night lights could cut the success rate of breast cancer therapy,... breast cancer therapy total nighttime darkness may https://scienmag.com/tag/pyroptosis-in-breast-cancer-therapy/ pyroptosis in breast cancer therapy | Science breast cancer therapy pyroptosis science https://jns.kashanu.ac.ir/article_114769.html Recent Updates on Chemotherapy of Pt Complexes and Pt Nano-Composites for Breast Cancer Therapy: A... Breast cancer continues to be one of the most widespread cancers globally, underscoring the need for the ongoing development of treatment strategies to enhance... breast cancer therapy recent updates chemotherapy pt complexes https://researchportal.bath.ac.uk/en/publications/steroid-sulphatase-inhibitors-for-breast-cancer-therapy/ Steroid sulphatase inhibitors for breast cancer therapy - the University of Bath's research portal breast cancer therapy university of bath research portal steroid inhibitors https://www.ispor.org/heor-resources/news-top/heor-news-desk/lower-recurrence-rates-drive-cost-effectiveness-of-breast-cancer-therapy-in-colombian-modeling-study ISPOR - Lower Recurrence Rates Drive Cost-Effectiveness of Breast Cancer Therapy in Colombian... breast cancer therapy cost effectiveness ispor lower recurrence https://repository.up.ac.za/items/45e6f6d5-8be6-40bb-85f6-da3eaed888f7 Overcoming the challenges of phytochemicals in triple negative breast cancer therapy : the path... Triple negative breast cancer (TNBC) is a very aggressive subtype of breast cancer that lacks estrogen, progesterone, and HER2 receptor expression. TNBC is... triple negative breast the challenges cancer therapy overcoming phytochemicals https://scholars.houstonmethodist.org/en/publications/nanotechnology-for-breast-cancer-therapy/ Nanotechnology for breast cancer therapy - Houston Methodist Scholars breast cancer therapy houston methodist nanotechnology scholars https://www.survivingbreastcancer.org/blog/tags/breast-cancer-therapy breast cancer therapy | SurvivingBreastCancer.org breast cancer therapy survivingbreastcancer https://www.womenfitness.net/news-flash/breast-cancer-therapy-heart/ Breast cancer therapy: All clear for the heart - Women Fitness Breast cancer is the second most frequent cancer worldwide and the most common cancer in women. About 70,000 women are diagnosed with breast cancer in Germany... breast cancer therapy all clear women fitness heart https://www.immunitytherapycenter.com/blog/category/breast-cancer/ Breast Cancer Archives - Immunity Therapy Center breast cancer therapy center archives immunity https://www.aacr.org/patients-caregivers/progress-against-cancer/her2-targeting-therapy-for-her2-ultralow-breast-cancer/ HER2-targeting Therapy for HER2-ultralow Breast Cancer | Research | AACR Feb 11, 2025 - The FDA has approved fam-trastuzumab deruxtecan-nxki (also called T-DXd) as a treatment for certain HER2-low or HER2-ultralow breast cancers. breast cancer research targeting therapy aacr https://comum.rcaap.pt/entities/publication/0b2d69f7-7060-4b20-ba3a-b05cc4982e22 Microbiome and response to therapy in triple negative breast cancer: a systematic review Objectives: Triple-negative breast cancer (TNBC) accounts for approximately 15% of all invasive breast cancers and is characterized by aggressive behavior,... triple negative breast systematic review microbiome response therapy https://wfamilymedicine.com/health-news/researchers-discover-potential-new-therapy-for-chemotherapy-resistant-breast-cancer/ Researchers discover potential new therapy for chemotherapy-resistant breast cancer - Worlds Family... Jan 19, 2021 - Scientists have discovered a molecule that can selectively kill cells breast cancer researchers discover potential new https://www.mayo.edu/research/clinical-trials/cls-20584399?&p=1 Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer - Mayo Clinic proton therapy early stage mayo clinic partial breast https://www.asiancancer.com/en/patients-stories/breast-cancer/825.html Mrs. Xu in her sixties successfully fights against breast cancer with interventional therapy |... Her condition is controlled through minimally invasive treatment and cautious care from the doctors and nurses in Modern Cancer Hospital Guangzhou. She is Mrs.... against breast cancer interventional therapy mrs xu sixties https://rxwiki.com/news-article/researchers-find-women-who-begin-hormone-replacement-therapy-earlier-increase-their Earlier Hormone Replacement Therapy Linked to Breast Cancer | RxWiki Women who start hormone replacement therapy (HRT) as menopause begins have a higher risk of breast cancer than women who... hormone replacement therapy breast cancer earlier linked https://www.azolifesciences.com/news/20210426/Researchers-hope-to-make-estrogen-therapy-a-more-accessible-treatment-for-breast-cancer-patients.aspx Researchers hope to make estrogen therapy a more accessible treatment for breast cancer patients Apr 26, 2021 - Researchers at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) hope to make estrogen therapy a more accessible treatment option for... to make estrogen therapy more accessible treatment for breast cancer https://www.mayoclinic.org/tests-procedures/radiation-therapy-for-breast-cancer/about/pac-20384940 Radiation therapy for breast cancer - Mayo Clinic Find out why doctors use radiation treat breast cancer. Learn what to expect and the side effects of breast cancer radiation, including proton therapy. radiation therapy breast cancer mayo clinic https://ctv.veeva.com/study/emotional-distress-in-patients-with-metastatic-breast-cancer-in-first-line-of-therapy Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy Few data about the impact of emotional distress (ED) on treatment efficacy in patients with metastatic breast cancer (mBC) are available. Aim of this study is... metastatic breast cancer emotional distress in patients first line therapy https://www.epistemonikos.org/en/documents/ca76ad7cbbcaacf0ecb1459796d690843c51176a Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer. BACKGROUND: Trastuzumab is a monoclonal antibody that together with chemotherapy significantly improves time to progression and overall survival for metastat... metastatic breast cancer cost effectiveness testing therapy https://eurobroadcastnews.com/article/835768977-a-novel-therapy-eradicates-triple-negative-breast-cancer-recurrence-in-preclinical-models A novel therapy eradicates triple negative breast cancer recurrence in preclinical models | Euro... Euro Broadcast News is an online news publication focusing on the Europe: Following the news from Europe triple negative breast cancer recurrence novel therapy preclinical https://www.dkfz.de/en/news/press-releases/detail/immune-cells-predict-therapy-response-in-breast-cancer Immune cells predict therapy response in breast cancer - German Cancer Research Center When immune cells invade the tumor, this is usually considered a good sign because the body's own immune system appears to be responding to the cancer. In the... immune cells breast cancer german research predict therapy https://www.tricountynews.com/articles/advances-in-breast-cancer-detection-and-therapy/ Advances in breast cancer detection and therapy - Tri-County News Jun 26, 2003 - A malignant tumor in the breast is the most common cancer among women. Each year more than 180,000 new cases are diagnosed in the United States. In Minnesota,... breast cancer detection tri county advances therapy news https://investigadores.uandes.cl/en/publications/use-of-hormone-therapy-for-menopausal-symptoms-and-quality-of-lif/ Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe... hormone therapy menopausal symptoms and quality life in breast cancer https://worldhealth.net/news/long-term-impact-hormone-therapy-breast-cancer-risk/ The Long-Term Impact of Hormone Therapy on Breast Cancer Risk - WorldHealth.net Aug 26, 2020 - For several decades, hormone therapy and its risk-to-benefit ratio have been a controversial topic within the scientific community. First published in 2002,... breast cancer risk long term hormone therapy impact https://research.ucc.ie/en/publications/combination-epigenetic-therapy-in-advanced-breast-cancer-with-5-a/ Combination epigenetic therapy in advanced breast cancer with 5-azacitidine and entinostat: A phase... advanced breast cancer epigenetic therapy combination phase https://archive.kuow.org/2017-10-21/many-breast-cancer-patients-receive-more-radiation-therapy-than-needed Many Breast Cancer Patients Receive More Radiation Therapy Than Needed breast cancer radiation therapy many patients receive https://www.cancernetwork.com/view/breast-cancer-tumors-respond-sorafenib-pemetrexed-combination-therapy Breast Cancer Tumors Respond to Sorafenib, Pemetrexed Combination Therapy | CancerNetwork May 17, 2026 - A new combination therapy is showing promise for treating advanced solid tumors and may especially be beneficial in patients with recurrent or metastatic... breast cancer combination therapy tumors respond pemetrexed https://www.medstarhealth.org/news-and-publications/patient-stories-and-testimonials/proton-therapy-and-coordinated-care-bring-late-stage-breast-cancer-into-remission Proton therapy and coordinated care bring late-stage breast cancer into remission In 2020, Tiffany Gannon was a highly successful professional at a consulting agency and a dog lover with two of her own when she started to notice subtle... proton therapy coordinated care late stage breast cancer bring https://cor2ed.com/precision-oncology-connect/programmes/molecular-testing-targeted-therapy-metastatic-breast-cancer/ HR+/HER2- metastatic breast cancer: Testing & targeted therapy metastatic breast cancer targeted therapy hr testing https://source.washu.edu/2021/02/imaging-identifies-breast-cancer-patients-unlikely-to-benefit-from-hormone-therapy/ Imaging identifies breast cancer patients unlikely to benefit from hormone therapy - The Source -... Feb 9, 2021 - In a small study, researchers at Washington University School of Medicine found that only women whose tumors responded to estrogen challenge benefited from... breast cancer hormone therapy imaging patients unlikely https://yourhealth247.com/experts-call-for-change-of-heart-on-hormone-replacement-therapy-after-breast-cancer/ Experts call for change of heart on hormone replacement therapy after breast cancer - Your Health... Sep 30, 2025 - Credit: Unsplash/CC0 Public Domain Breast cancer survivors with severe menopausal symptoms should be supported to make an informed decision about change of heart hormone replacement therapy after breast cancer your health experts https://www.pharmafocusasia.com/technotrends/breakthrough-gedatolisib-therapy-discovered-for-the-treatment Breakthrough Gedatolisib Therapy Discovered for the Treatment of Metastatic Breast Cancer Celcuity Inc discovered Gedatolisib new therapy for the treatment of HR+/HER2- Metastatic Breast Cancer. Gedatolisib, the first-in-class pan-PI3K/mTOR... metastatic breast cancer for the breakthrough gedatolisib therapy https://www.walshmedicalmedia.com/proceedings/oncolytic-hsv1-therapy-for-breast-cancer-meningeal-metastases-17365.html Oncolytic HSV-1 therapy for breast cancer meningeal metastases | 17365 Meningeal metastasis is a fatal complication of breast cancer that affects 5-8% of patients when cancer cells seed in the meninges. Their subsequent... breast cancer hsv therapy metastases